Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
This study has been completed.
Study NCT00079638 Information provided by Kos Pharmaceuticals
First Received: March 10, 2004 Last Updated: October 31, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dyslipidemia
Coronary Heart Disease
Atherosclerosis
Stroke
Diabetes
Additional conditions recognized in this trial
Coronary Artery Disease
Coronary Disease
Dyslipidemias
Heart Diseases
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Lipid Metabolism Disorders
Metabolic Diseases
Myocardial Ischemia
Nervous System Diseases
Vascular Diseases
Interventions listed in this trial
Niacin
Atorvastatin
Simvastatin
Ezetimibe
Rosuvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antilipemic Agents
Antimetabolites
Cardiovascular Agents
Enzyme Inhibitors
Growth Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Kos Pharmaceuticals
Back to top of Main Content
